Engineering platforms for localized long-acting immune modulation - 08/03/24
![](/templates/common/images/mail.png)
Abstract |
Systemic immunotherapeutics have been a clinical staple in the treatment of cancer, infectious diseases, organ and cell transplantation, autoimmunity, and allergies. Although their utility remains unquestioned, systemic administration of these drugs is associated with limited efficacy, significant adverse off-target effects, transient activity, and the requirement for frequent repeated dosing. To this end, recent technological advancements have provided novel means for sustained drug delivery to specific tissues and targeted localized approaches for immunotherapeutics. In this article, we present various cutting-edge platform technologies, including implants, multireservoir systems, and scaffolds encapsulating immunomodulatory agents for local administration. Examples of their application in cancer, cell transplantation, allergy, and infectious diseases are discussed, highlighting the potential of such systems for innovative immunomodulatory intervention.
Le texte complet de cet article est disponible en PDF.Key words : Immunomodulation, long-acting drug delivery, immunomodulatory therapies, cancer, allergy, transplantation
Abbreviations used : AIT, APC, Cas9, CRISPR, CTLA-4, 3D, DC, FLT3L, SIVET, T1D
Plan
Vol 153 - N° 3
P. 572-575 - mars 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?